Magnetic resonance imaging (MRI) and spectroscopy are diagnostic tools that create high
quality images of the human body without the use of X-ray (radiation). MRI uses different
levels of magnetic fields to create images of the body and organs. Occasionally, researchers
will give patients undergoing a MRI an injection of a contrast substance. The contrast
substance works by brightening areas of the magnetic resonance image.
In this study researchers plan to use magnetic resonance imaging with contrast substances
and exercise on normal volunteers in order to evaluate different aspects of its performance.
Information gathered from this study may be used to develop more specific research studies
Technical evaluation of magnetic resonance imaging and spectroscopy will be performed on
normal volunteers. These studies will be conducted in the NIH MRI systems located in
Suburban Hospital in Bethesda, Maryland. These studies may involve the intravenous
administration of commercially available MR contrast media and exercise. The results will be
used to evaluate the performance of various pulse sequences, gradient coils, and RF coils on
human subjects and will provide essential ground work for specific patient protocols.
- INCLUSION CRITERIA:
Any normal volunteer above the age 18 who is capable of giving informed consent will be
A subject will be excluded if he/she has a contradiction to MR scanning.
1. Brain aneurysm clip
2. Implanted neural stimulator
3. Implanted cardiac pacemaker implanted defibrillator
4. Cochlear implant
5. Ocular foreign body (e.g. metal shavings)
6. Insulin pump
7. Pregnant women (when uncertain, subjects will undergo urine or blood testing).
9. Paralyzed hemidiaphragm
10. Morbid obesity
12. Any condition in the PI's judgement which present unncessary risk
EXCLUSION CRITERIA FOR GADOLINIUM ENHANCED STUDIES:
1. Lactating women
2. Subjects with hemoglobinopathies
4. Renal or hepatic disease
Subjects will be excluded if it is deemed that they have a condition that would preclude
their use for technical development (e.g. paralyzed hemidiaphragm, morbid obesity,
claustrophobia etc.) or present unnecessary risk (e.g. pregnancy, surgery of uncertain
Lactating women and subjects with hemoglobinopathies, asthma, or renal or hepatic disease
will be excluded from studies involving the adminstration of contrast agents.